Cargando…
Eosinophilia is Associated with Improved COVID-19 Outcomes in Patients Treated with Inhaled Corticosteroids
Autores principales: | Strauss, Ronald, Zein, Joe, Attaway, Amy, Milinovich, Alex, Jawhari, Nesreen, Chamat, Soulaima, Ortega, Victor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Mosby, Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8804538/ http://dx.doi.org/10.1016/j.jaci.2021.12.626 |
Ejemplares similares
-
Eosinophilia Is Associated with Improved COVID-19 Outcomes in Inhaled Corticosteroid-Treated Patients
por: Zein, Joe G., et al.
Publicado: (2022) -
Intranasal Corticosteroids Are Associated with Better Outcomes in Coronavirus Disease 2019
por: Strauss, Ronald, et al.
Publicado: (2021) -
Reply to "A limitation regarding the association between intranasal corticosteroid use and better COVID-19 outcomes: Nasal symptoms matter"
por: Strauss, Ronald, et al.
Publicado: (2022) -
Inhaled corticosteroids do not adversely impact outcomes in COVID-19 positive patients with COPD: An analysis of Cleveland Clinic’s COVID-19 registry
por: Sen, Payal, et al.
Publicado: (2021) -
Blood eosinophilia, use of inhaled corticosteroids, and risk of COPD exacerbations and mortality
por: Oshagbemi, Olorunfemi A., et al.
Publicado: (2018)